Ventyx Biosciences Stock Operating Margin
| VTYX Stock | USD 2.83 0.17 5.67% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Ventyx Biosciences' long-term financial health and intrinsic value.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Ventyx Biosciences Company Operating Margin Analysis
Ventyx Biosciences' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Ventyx Biosciences has an Operating Margin of 0.0%. This is 100.0% lower than that of the Pharmaceuticals sector and 100.0% lower than that of the Health Care industry. The operating margin for all United States stocks is 100.0% lower than that of the firm.
Ventyx Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ventyx Biosciences' direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Ventyx Biosciences could also be used in its relative valuation, which is a method of valuing Ventyx Biosciences by comparing valuation metrics of similar companies.Ventyx Biosciences is currently under evaluation in operating margin category among its peers.
Ventyx Fundamentals
| Return On Equity | -0.49 | ||||
| Return On Asset | -0.3 | ||||
| Current Valuation | 3.14 M | ||||
| Shares Outstanding | 71.31 M | ||||
| Shares Owned By Insiders | 4.11 % | ||||
| Shares Owned By Institutions | 68.25 % | ||||
| Number Of Shares Shorted | 4.75 M | ||||
| Price To Book | 0.96 X | ||||
| EBITDA | (133.77 M) | ||||
| Net Income | (135.12 M) | ||||
| Cash And Equivalents | 250.45 M | ||||
| Cash Per Share | 4.92 X | ||||
| Total Debt | 10.79 M | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 14.27 X | ||||
| Book Value Per Share | 2.94 X | ||||
| Cash Flow From Operations | (130.87 M) | ||||
| Short Ratio | 3.76 X | ||||
| Earnings Per Share | (1.66) X | ||||
| Target Price | 11.5 | ||||
| Number Of Employees | 81 | ||||
| Beta | 0.97 | ||||
| Market Capitalization | 201.8 M | ||||
| Total Asset | 276.56 M | ||||
| Retained Earnings | (554.31 M) | ||||
| Working Capital | 216.85 M | ||||
| Net Asset | 276.56 M |
About Ventyx Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ventyx Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ventyx Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ventyx Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| HLN | Haleon plc | |
| NVDA | NVIDIA | |
| INTC | Intel |
Additional Tools for Ventyx Stock Analysis
When running Ventyx Biosciences' price analysis, check to measure Ventyx Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ventyx Biosciences is operating at the current time. Most of Ventyx Biosciences' value examination focuses on studying past and present price action to predict the probability of Ventyx Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ventyx Biosciences' price. Additionally, you may evaluate how the addition of Ventyx Biosciences to your portfolios can decrease your overall portfolio volatility.